Cansortium(US OTC: CNTMF: $0.77):Q3 EBITDA Outperformance Despite FL Pricing Pressure; Remains on Track to Scale CapacityCansortium reported Q3/21 results of $16M in revenues and $4.9M adjusted EBITDA. Revenues came in modestly below our forecastof $18M while adjusted EBITDA exceeded our estimate of $3.9M on higher than anticipated gross margins on achieved operational efficiencies
FREE Battery with any Cart Purchase Today Only🎁
Related posts
Articles
The Mothers of Cannabis: Celebrating Women’s Impact on the Cannabis Industry
In the expansive realm of cannabis, numerous pioneering women have played crucial roles that not only shaped the history of this dynamic field but also
Articles
Celebrating “5-10 Day” – Exploring the Versatility of 510 Cartridges
Welcome to “5-10 Day” at FLUENT, where we spotlight the convenience and variety of 510 cartridges, a staple in the world of vaping. Whether you’re
Advanced Cannabis
How to Use an RSO Syringe
Rick Simpson Oil (RSO) has become a distinguished player in the cannabis market for its potent therapeutic benefits, particularly noted for its high THC concentration